Suzanne Blaug
Direktor/Vorstandsmitglied bei FIBROGEN, INC.
Vermögen: 21 731 $ am 30.04.2024
Aktive Positionen von Suzanne Blaug
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| FIBROGEN, INC. | Direktor/Vorstandsmitglied | 05.06.2019 | - |
| Independent Dir/Board Member | 05.06.2019 | - |
Karriereverlauf von Suzanne Blaug
Ehemalige bekannte Positionen von Suzanne Blaug
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AMGEN INC. | Vertrieb & Marketing | 01.04.2012 | 01.08.2018 |
| Janssen Alzheimer Immunotherapy | Corporate Officer/Principal | 01.10.2009 | 01.03.2012 |
Janssen Global Services LLC
 Janssen Global Services LLC Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Janssen Global Services LLC develops treatments for patients in therapeutic areas of healthcare. The company is based in Raritan, NJ. | Corporate Officer/Principal | 01.03.2004 | 01.10.2009 |
EMEA Capital LLP
 EMEA Capital LLP Investment ManagersFinance EMEA Capital LLP is a privately-held investment management firm which was founded by Osman Semerci in 2008. Headquartered in London, the firm provides asset management services to individual and institutional clients. | Corporate Officer/Principal | - | - |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01.01.2004 | - |
Ausbildung von Suzanne Blaug
| Kellogg School of Management | Masters Business Admin |
| The University of North Carolina at Chapel Hill | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 8 |
| Vereinigtes Königreich | 2 |
Operativ
| Corporate Officer/Principal | 4 |
| Sales & Marketing | 1 |
| Masters Business Admin | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| AMGEN INC. | Health Technology |
| FIBROGEN, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
| Janssen Alzheimer Immunotherapy | |
EMEA Capital LLP
EMEA Capital LLP Investment ManagersFinance EMEA Capital LLP is a privately-held investment management firm which was founded by Osman Semerci in 2008. Headquartered in London, the firm provides asset management services to individual and institutional clients. | Finance |
Janssen Global Services LLC
Janssen Global Services LLC Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Janssen Global Services LLC develops treatments for patients in therapeutic areas of healthcare. The company is based in Raritan, NJ. | Health Technology |
- Börse
- Insiders
- Suzanne Blaug
- Erfahrung
